| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |